Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
VXRT · against 454 other Healthcare companies listed in US-listed
Ranked #2 of 455 · scores higher than 98% of peers
Bars: peers in each 10-point band of the growth score85 peers with a growth score of 90–100, including VXRT · Click a bar to see the companies
Mainly thanks to its 3-year revenue growth and revenue growth, which are stronger than most Healthcare peers.
| Metric | VXRT | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 475 reported | 726.7% | 11.0% | 97% | 33% | |
| Earnings per share growthHigher is better · 171 reported | Not reported | 21.2% | — | — | 33% |
| 3-year revenue growthHigher is better · 433 reported | 1204.0% | 11.0% | 100% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 464M USD | 100 | 53 | |
| 2 | 1.4B USD | 99 | 73 | |
| 2 | 433M USD | 99 | 81 | |
| 2 | 8.8B USD | 99 | 31 | |
| 2 | 90M USD | 99 | 27 | |
| 2 | 2.1B USD | 99 | 96 | |
| 2 | 9M USD | 99 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score
| 45 |
| 2 | 2.8B USD | 99 | 51 |
| 2 | 885M USD | 99 | 33 |
| 2 | 97M USD | 99 | 63 |
| 2 | 609M USD | 99 | 91 |
| 12 | 595M USD | 98 | 97 |
| 12 | 3.8B USD | 98 | 71 |
| 12 | 914M USD | 98 | 81 |